指南与共识免疫规划卫生政策与健康促进

将中年成人HPV疫苗接种指南落实到临床实践

Implementation of mid-adult HPV vaccination guidelines into clinical practice.
指南 / 共识 · Vaccine · 2025-02-15

本研究调查美国600名服务中年成人的医护人员对2019年美国指南推荐的中年成人(27-45岁)HPV疫苗接种共同临床决策(SCDM)的实施情况。约47%的医护人员经常或总是进行SCDM,50%提供HPV疫苗,且因医护人员类型而异(p<0.01)。主要障碍为时间有限(67%)和认为患者保险覆盖不足(65%)。

要点

  • 约47%的医护人员经常或总是对中年成人HPV疫苗接种进行共同临床决策。
  • 50%的医护人员提供HPV疫苗,提供频率因医护人员类型显著不同(p<0.01)。
  • 主要障碍为时间有限(67%)和认为患者保险覆盖不足(65%)。

核心结论

  • 尽管中年成人HPV疫苗接种的共同临床决策指南已获批,但不同医护人员类型的实施不一致,并受特定患者人口学特征影响。
  • 时间限制和保险问题等已识别的障碍阻碍了指南的统一采纳。
  • 未来举措应侧重于针对不同医护人员专业的定制干预,以促进一致和公平的医疗服务提供。

研究设计与样本

  • 对美国600名服务中年成人的医护人员进行配额抽样调查,了解其HPV疫苗接种实践及SCDM指南实施情况。
  • 调查收集描述性统计并进行双变量分析。

主要发现

  • 约47%的医护人员经常或总是对HPV疫苗接种进行共同临床决策。
  • 50%的医护人员提供HPV疫苗,且因医护人员类型显著不同(p<0.01)。
  • 妇产科医生总是提供疫苗的频率最高(26%),家庭医学(10%)和内科(12.5%)医护人员较低。
  • 主要障碍为时间有限(67%)和认为患者保险覆盖不足(65%)。

关键数值与推荐

  • 2019年美国指南推荐对中年成人(27-45岁)HPV疫苗接种进行共同临床决策(SCDM)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study investigates the implementation of the 2019 U.S. guideline recommending shared clinical decision-making (SCDM) for HPV vaccination among mid-adults (ages 27-45) by health care providers. METHODS: A quota sample of 600 health care providers serving mid-adults in the U.S. was surveyed on their practices regarding HPV vaccination and the implementation of the SCDM guideline. The survey collected descriptive statistics and conducted bivariate analyses. RESULTS: Approximately 47 % of providers often or always engaged in shared clinical decision-making for HPV vaccinations, and 50 % offered the HPV vaccine, which significantly varied by provider type (p < 0.01). OB/GYNs had the highest frequency of always offering the vaccine (26 %), compared to family medicine (10 %) and internal medicine (12.5 %) providers. The major barriers identified were limited time (67 %) and perceived inadequate patient insurance coverage (65 %). CONCLUSIONS: Despite approval of the shared clinical decision-making guideline for mid-adult HPV vaccination, implementation is inconsistent across different provider types, influenced by specific patient demographics. The identified barriers, including time constraints and insurance issues, impede uniform adoption of the guideline. Future initiatives should focus on tailored interventions for different provider disciplines to promote consistent and equitable health care delivery.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Thompson EL, Akpan IN, Alkhatib S, et al. Implementation of mid-adult HPV vaccination guidelines into clinical practice. Vaccine. 2025. PMID: 39956086. doi:10.1016/j.vaccine.2025.126867

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。